The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Circulating biomarkers for early detection and clinical management of colorectal cancer
Open accessAbstract
New non-invasive approaches that can complement and improve on current strategies for colorectal cancer (CRC) screening and management are urgently needed. A growing number of publications have documented that components of tumors, which are shed into the circulation, can be detected in the form of liquid biopsies and can be used to detect CRC at early stages, to predict response to certain therapies and to detect CRC recurrence in a minimally invasive way. The analysis of circulating tumor DNA (ctDNA), tumor-derived cells (CTC, circulating tumor cells) or circulating microRNA (miRNA) in blood and other body fluids, have a great potential to improve different aspects of CRC management. The challenge now is to find which types of components, biofluids and detection methods would be the most suitable to be applied in the different steps of CRC detection and treatment. This chapter will provide an up to date review on ctDNA, CTCs and circulating miRNAs as new biomarkers for CRC, either for clinical management or early detection, highlighting their advantages and limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–225 of 225
Expression analysis of microRNA as prognostic biomarkers in colorectal cancer
Yang, J., Ma, D., Fesler, A. T., Zhai, H., Leamniramit, A., Li, W., Wu, S., & Ju, J. (2016) · Oncotarget · doi:10.18632/oncotarget.14175 · Cited by 58
Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
Philipp, A. B., Nagel, D., Stieber, P., Lamerz, R., Thalhammer, I., Herbst, A., & Kolligs, F. T. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-245 · Cited by 56
Cell‐free DNA copy number variations in plasma from colorectal cancer patients
Li, J., Dittmar, R. L., Xia, S., Zhang, H., Du, M., Huang, C., Druliner, B. R., Boardman, L., & Wang, L. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12077 · Cited by 55
Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma
ZHANG, G.-J., Zhou, T., Liu, Z.-L., Tian, H., & Xia, S. (2013) · Molecular and Clinical Oncology · doi:10.3892/mco.2013.61 · Cited by 53
Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
Avraham, A., Uhlmann, R., Shperber, A., Birnbaum, M., Sandbank, J., Sella, A., Sukumar, S. V., & Evron, E. (2012) · International Journal of Cancer · doi:10.1002/ijc.27526 · Cited by 53
Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery
Rotelli, M. T., Lena, M. D., Cavallini, A., Lippolis, C., Bonfrate, L., Chetta, N., Portincasa, P., & Altomare, D. F. (2015) · International Journal of Colorectal Disease · doi:10.1007/s00384-015-2248-0 · Cited by 52
Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers
Danese, E., & Montagnana, M. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.45 · Cited by 52
Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer
Lim, S. H.-S., Becker, T. M., Chua, W., Ng, W. L., SOUZA, P. D., & Spring, K. J. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202499 · Cited by 50
Systemic mirnas as potential biomarkers for malignancy
Healy, N. A., Heneghan, H., Miller, N., Osborne, C. K., Schiff, R., & Kerin, M. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27642 · Cited by 49
Carter, J. V., Roberts, H. L., Pan, J., Rice, J. D., Burton, J. F., Galbraith, N. J., Eichenberger, M. R., Jorden, J., Deveaux, P. G., Farmer, R. W., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001873 · Cited by 48
The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen, W., Zhao, X., Yu, Z., Hu, F., Liu, Y., Cui, B., Dong, X., & Zhao, Y. (2015) · Europe PMC (PubMed Central) · Cited by 45
Liquid Biopsy in Colorectal Cancer-Current Status and Potential Clinical Applications
Norčič, G. (2018) · Micromachines · doi:10.3390/mi9060300 · Cited by 40
Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers
Wu, C. W., Cao, X., Berger, C. K., Foote, P. H., Mahoney, D. W., Simonson, J. A., Anderson, B. W., Yab, T. C., Taylor, W. R., Boardman, L. A., et al. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4627-6 · Cited by 37
Alberter, B., Klein, C. A., & Polzer, B. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1121099 · Cited by 36
Expression profile of miR-17/92 cluster is predictive of treatment response in rectal cancer
Král, J., Korenková, V., Novosadová, V., Langerová, L., Schneiderová, M., Liška, V., Levý, M., Veškrňová, V., Špičák, J., Opattová, A., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy100 · Cited by 34
Self-citationA feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection
Molparia, B., Oliveira, G., Wagner, J. L., Spencer, E. G., & Torkamani, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196826 · Cited by 33
Yu, Y., Majumdar, A. P. N., Nechvatal, J. M., Ram, J. L., Basson, M. D., Heilbrun, L. K., & Kato, I. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2515 · Cited by 32
A Novel Method to Detect Early Colorectal Cancer Based on Chromosome Copy Number Variation in Plasma
Xu, J., Kang, Q., Ma, X.-Y., Pan, Y., Yang, L., Jin, P., Wang, X., Li, C., Chen, X., Wu, C., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487571 · Cited by 31
Liang, P. S., & Dominitz, J. A. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.08.010 · Cited by 31
Wang, X., Shi, X., Zeng, P., Mo, F., & Chen, Z. (2018) · Oncotarget · doi:10.18632/oncotarget.25314 · Cited by 30
One size does not fit all: Size-based plasma DNA diagnostics
Heitzer, E., & Speicher, M. R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aav3873 · Cited by 30
Self-citationDiagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva
Igaz, I., & Igaz, P. (2015) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0955-9_11 · Cited by 26
Epigenomic technologies for deciphering circulating tumor DNA
Daniūnaitė, K., Jarmalaitė, S., & Kriukienė, E. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.07.002 · Cited by 13
MicroRNAs: Emerging Novel Targets of Cancer Therapies
Yang, C., Jiang, Y., Singh, A. P., & Takeshita, F. (2015) · BioMed Research International · doi:10.1155/2015/506323 · Cited by 9
A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer
Liu, T., Yin, L., Yan, G., Li, C., & Wang, L. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2018.64.6.15 · Cited by 7
Cited by
Circulating tumor cells: biology and clinical significance
Lin, D., Shen, L., Luo, M., Zhang, K., Li, J., Yang, Q., Zhu, F., Zhou, D., Zheng, S., Chen, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00817-8 · Cited by 993
Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., & Przybyłowicz, K. E. (2021) · Cancers · doi:10.3390/cancers13092025 · Cited by 921
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
Dong, S., Liang, S., Cheng, Z., Zhang, X., Luo, L., Li, L., Zhang, W., Li, S., Xu, Q., Zhong, M., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02229-6 · Cited by 458
ctDNA as a cancer biomarker: A broad overview
Pessoa, L. S., Heringer, M., & Ferrer, V. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103109 · Cited by 298
Metadata
- Authors
- Marcuello, M., Vymetalkova, V., Neves, R. P. L., Duran-Sanchon, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., Garcia-Barberan, V., Fijneman, R. J., Castells, A., Vodicka, P., Lind, G. E., Stoecklein, N. H., Heitzer, E., & Gironella, M.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 69
- Pages
- 107-122
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2950512766
- Cited by
- 275
- References
- 225
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.